MediPharm Labs Announces Listing on Frankfurt Stock Exchange
February 19, 2019 09:04 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation,...
MediPharm Labs Announces Listing on Frankfurt Stock Exchange
February 19, 2019 08:20 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation,...
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million
February 12, 2019 06:30 ET
|
MediPharm Labs Corp.
TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (“MediPharm”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is...
IntelGenx Provides Update on Cannabis-Infused VersaFilm™ Program Following Recently Proposed Amendments to the Cannabis Act
January 14, 2019 08:00 ET
|
IntelGenx Technologies Corp.
Working with partner Tilray®, IntelGenx aims to launch oral film products in late-2019 SAINT LAURENT, Quebec, Jan. 14, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT)...
IntelGenx Closes Private Placement Financing
November 13, 2018 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 13, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX) (OTCQX:IGXT) (the “Company” or “IntelGenx”) announces the closing of Tilray, Inc.’s strategic...
IntelGenx Reports Third Quarter 2018 Financial Results
November 08, 2018 16:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm™ Products
November 07, 2018 08:00 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced the execution of a definitive...
Streetwise Reports Examines a Cannabis Company that Has Better Numbers than Tilray at 1/25th the Price
September 25, 2018 13:17 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Tilray's wild fluctuations have grabbed the headlines the past few days, but Fincom Investment Partners profiles a rapidly emerging player in the...
IntelGenx Signs Letter of Intent with Tilray® to Enter Into a World-Wide Agreement To Produce Cannabis-Infused VersaFilm™ Products
September 20, 2018 00:01 ET
|
IntelGenx Technologies Corp.
SAINT LAURENT, Quebec, Sept. 20, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) today announced that it has executed a non-binding letter of intent (the “LOI”) with...
CV Sciences, Inc. provides corporate update to shareholders
August 30, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent...